Preclinical studies in WT and Selplg−/− mice showed that mice injected with melanoma cell lines (YUMM1.5) developed subcutaneous tumors, however Selplg−/− mice had increased infiltration of effector CD4+ and CD8+ T cells. This evidence concerns the gene SELPLG and melanoma.